Global BioClinical Revenue and Competitors
Estimated Revenue & Valuation
- Global BioClinical's estimated annual revenue is currently $1.1M per year.
- Global BioClinical's estimated revenue per employee is $155,000
Employee Data
- Global BioClinical has 7 Employees.
- Global BioClinical grew their employee count by 0% last year.
Global BioClinical's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Founder | Reveal Email/Phone |
2 | Senior Clinical Research Manager | Reveal Email/Phone |
3 | Clinical Research Associate | Reveal Email/Phone |
Global BioClinical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Global BioClinical?
Expertise-Based Clinical Research Services - Consulting - Business - Trials - Biospecimens Global BioClinical (GBC) provides consulting services for organizations in the life sciences sector including venture capital, biotechnology, pharmaceutical research, medical centers, academic institutions, governments and not-for-profit companies. GBC has a global vision and offers a full range of strategic, competitive and operational services that prepare clients to develop new programs, services and products at the lowest cost and with the best result. www.globalbioclinical.com 1-888-659-1221
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 7 | 0% | N/A |
#2 | $0.5M | 7 | N/A | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.9M | 7 | N/A | N/A |
#5 | N/A | 7 | 17% | N/A |